Welcome to our dedicated page for Biolargo news (Ticker: BLGO), a resource for investors and traders seeking the latest updates and insights on Biolargo stock.
BioLargo, Inc. (OTCQX: BLGO) regularly issues news and updates about its cleantech, environmental, energy, and life sciences activities. As a developer of sustainable technologies and a full-service environmental engineering company, its announcements often focus on progress in PFAS water treatment, advanced wastewater solutions, odor and VOC control, air quality, energy storage, and medical infection control and wound care.
Recent news has highlighted BioLargo’s Aqueous Electrostatic Concentrator (AEC) platform, including reported breakthroughs that significantly reduced the system’s energy use in large-scale PFAS treatment and its deployment at a municipal drinking water facility in Lake Stockholm, New Jersey. Coverage also includes recognition of BioLargo Equipment Solutions & Technologies, Inc. in industry media for PFAS treatment advances and updates on commercial demonstration projects.
Investors and observers can also find announcements about BioLargo’s Cellinity battery technology for grid-scale energy storage, its role in broader infrastructure and clean energy discussions, and participation in conferences and investor events such as LD Micro and NobleCon. These items provide context on how the company positions its technologies within evolving infrastructure, data center, and energy investment cycles.
On the life sciences side, news items cover Clyra Medical Technologies’ progress in infection control and advanced wound care, including the ViaCLYR wound irrigation solution and its exclusive distribution alliance with Advanced Solution, LLC. Regulatory, legal, and corporate developments—such as SEC-reported events, financial updates, and intellectual property enforcement actions related to odor control technologies—are also common topics. This news page allows readers to follow BioLargo’s ongoing technical milestones, commercialization steps, and corporate disclosures in one place.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
BioLargo, a developer of sustainable cleantech technologies, announced its participation in the Sequire Investor Summit scheduled for April 24-26, 2023 at La Concha Resort, San Juan, Puerto Rico. The company's presentation will occur at 11:30 AM Eastern on April 25. CEO Dennis P. Calvert highlighted a remarkable 130% revenue growth in 2022, with plans to leverage this momentum in 2023 through the launch of new technologies and increased sales of its pet odor control product, Pooph. For further details about the event, interested parties can visit the official event website.
BioLargo, Inc. (OTCQB:BLGO) announced substantial financial progress in its Annual Report filed on March 31, 2023, revealing a 132% increase in revenues to $5.88 million for the year ended December 31, 2022. The net loss decreased by 26% to $5.13 million. Key highlights included significant revenue growth from the Pooph product and advancements in the PFAS treatment sector, with the company showcasing its capability to meet EPA standards for water contamination. Furthermore, BioLargo acquired IP rights to a sodium-sulfur battery technology, promising innovations in energy storage. The company will hold a public investor webcast on April 3, 2023, to discuss these developments.
BioLargo, Inc. (OTCQB:BLGO) will hold an investor webcast and conference call on April 3, 2023, at 1:30 pm Pacific / 4:30 pm Eastern to review its financial results for the fiscal year ending December 31, 2022. The public event will discuss recent milestones and include a Q&A session. Interested parties can register via the webcast link and will have access to a replay until April 17, 2023. BioLargo focuses on sustainable cleantech solutions addressing PFAS contamination and advanced water treatment. A replay of the webcast will be available for 90 days on their Investor Relations website.
FAQ
What is the current stock price of Biolargo (BLGO)?
What is the market cap of Biolargo (BLGO)?
